Blockade of estrogen receptor signaling to improve outlook for medulloblastoma sufferers

Future Oncology

Volumn 5, Issue 6, 2009, Pages 751-754

  Belcher, Scott M ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR BETA; FULVESTRANT; PROTEIN KINASE C; TAMOXIFEN;

BRAIN TUMOR; BREAST CANCER; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM TUMOR; DRUG MEGADOSE; EDITORIAL; ENZYME INHIBITION; HUMAN; MEDULLOBLASTOMA; NEUROECTODERM TUMOR; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SURVIVAL RATE; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CEREBELLAR NEOPLASMS; CHILD; CHILD, PRESCHOOL; DRUG SYNERGISM; ESTROGEN ANTAGONISTS; HUMANS; INFANT; MEDULLOBLASTOMA; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 70349209368     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.09.69     Document Type: Editorial

References (26)

1. Ries LAG, Smith MA, Gurney JG et al.: Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995. National Cancer Institute, SEER Program. NIH Pub. No. 99-4649. Bethesda, MD, USA (1999).
2. Rubin JB, Rowitch DH: Medulloblastoma: a problem of developmental biology. Cancer Cell. 2, 7-8 (2002).
3. Wechsler-Reya R, Scott MP: The developmental biology of brain tumors. Annu. Rev. Neurosci. 24, 385-428 (2001).
4. Gatta G, Capocaccia R, Coleman MP, Ries LA, Berrino F: Childhood cancer survival in Europe and the United States. Cancer 95, 1767-1772 (2002).
5. Gurney JG, Kadan-Lottick NS, Packer RJ et al.: Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood Cancer Survivor Study. Cancer 97, 663-673 (2003).
6. Gurney JG, Nus KK, Stovall M et al.: Final height and body mass index among adult survivors ofchildhood brain cancer: childhood cancer survivor study. J Clin. Endocrinol. Metab. 88, 4731-4739 (2003).
7. Mulhern RK, Merchant TE, Gajjar A, Reddick WE, Kun LE: Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol. 5, 399-408 (2004)
8. Packer RJ: Childhood medulloblastoma: progress and future challenges. Brain Dev. 21, 75-81 (1999).
9. Lee SJ, McEwen BS: Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications. Annu. Rev. Pharmacol. Toxicol. 41, 569-591 (2001).
10. McEwen B: Estrogen actions throughout the brain. Recent Prog. Horm. Res. 57, 357-384 (2002).
11. Belcher SM, Zsarnovszky A: Estrogenic actions in the brain: estrogen, phytoestrogens, and rapid intracellular signaling mechanisms. J. Pharmacol. Exp. Ther. 299, 408-414 (2001)
12. Falkenstein E, Tillman HC, Lost D, Feuring M, Lost D: Multiple actions of steroid hormones - a focus on rapid, nongenomic effects. Pharmacol. Rev. 52, 513-556 (2000).
13. Belcher SM: Regulated expression of estrogen receptor α and β mRNA in granule cells during development of the rat cerebellum. Brain Res. Dev. Brain Res. 115, 57-69 (1999).
14. Jakab RL, Wong JK, Belcher SM: Estrogen receptor-β immunoreactivity in differentiating cells of the developing rat cerebellum. J. Comp. Neurol. 430, 396-409 (2001).
15. Wong JK, Le HH, Zsarnovszky A, Belcher SM: Estrogens and ICI182,780 (Faslodex) modulate mitosis and cell death in immature cerebellar neurons via rapid activation of p44/p42 mitogen-activated protein kinase. J. Neurosci. 23, 4984 (2003).
16. Zsarnovszky A, Le HH, Wang HS, Belcher SM: Ontogeny of rapid estrogen-mediated ERK1/2 signaling in the rat cerebellar cortex in vivo: potent non-genomic agonist and endocrine disrupting activity of the xenoestrogen bisphenol A. Endocrinology 146, 5388-5396 (2005).
17. Belcher SM, Ma X, Le HH: Blockade of estrogen receptor signaling inhibits growth and migration of medulloblastoma. Endocrinology 150, 1112-1121 (2009).
18. Kirby M, Zsarnovszky A, Belcher SM: Estrogen receptor expression in a human primitive neuroectodermal tumor cell line from the cerebral cortex: estrogen stimulates rapid ERK1/2 activation and receptor-dependent cell migration. Biochem. Biophys. Res. Commun. 319, 753-758 (2004)
19. Ma ZQ, Spreafico E, Pollio G et al.: Activated estrogen receptor mediates growth arrest and differentiation of a neuroblastoma cell line. Proc. Natl Acad. Sci. USA 90, 3740-3744 (1993).
20. Leslie KK, Keefe D, Powell S, Naftolin F: Estrogen receptors are identified in the glioblastoma cell line U138MG. J. Soc. Gynecol. Investig. 1, 238-244 (1994).
21. Batistatou A, Stefanou D, Goussia A et al.: Estrogen receptor β (ERβ) is expressed in brain astrocytic tumors and declines with dedifferentiation of the neoplasm. J. Cancer Res. Clin. Oncol. 130, 405-410 (2004).
22. Broniscer A, Leite CdC, Lanchote VL, Machado TMS, Cristofani LM: Radiation therapy and high-dose tamoxifen in the treatment of patients with diffuse brainstem gliomas: results of a Brazilian cooperative study. J. Clin. Oncol. 18, 1246-1253 (2000)
23. Robins HI, Won M, Seiferheld WF et al.: Phase II trial of radiation plus high-dose tamoxifen for glioblastoma multiforme: RTOG protocol BR-0021. Neuro. Oncol. 8, 47-52 (2006).
24. Spence AM, Peterson RA, Scharnhorst JD, Silbergeld DL, Rostomily RC: Phase II study of concurrent continuous temozolomide (TMZ) and tamoxifen (TMX) for recurrent malignant astrocytic gliomas. J. Neurooncol. 70, 91-95 (2004).
25. Puchner MJ, Giese A, Lohmann F, Cristante L: High-dose tamoxifen treatment increases the incidence of multifocal tumor recurrences in glioblastoma patients. Anticancer Res. 24, 4195-4203 (2004).
26. vom Saal FS, Akingbemi BT, Belcher SM et al.: Chapel Hill bisphenol A expert panel consensus statement: Integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. Reprod. Toxicol. 24, 131-138 (2007).